Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-23-009983

Options or other derivatives

  • Director acquired 5,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pridgen William Director 2023-06-15 Grant or award · Stock Option (right to buy) +5,250 5,250 D
Loading xslF345X04/form4-06202023_050635.xml…